Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 6, p. 419, doi. 10.1007/s11899-020-00601-5
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2020 AND VI 15 AND IP 6
Results: 3
1
2
New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 6, p. 424, doi. 10.1007/s11899-020-00597-y
- By:
- Publication type:
- Article
3
The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib.
- Published in:
- Current Hematologic Malignancy Reports, 2020, v. 15, n. 6, p. 409, doi. 10.1007/s11899-020-00596-z
- By:
- Publication type:
- Article